Show simple item record

dc.contributor.authorMolassiotis, A
dc.contributor.authorStamataki, Z
dc.contributor.authorKontopantelis, E
dc.date.accessioned2013-10-29T11:58:58Z
dc.date.available2013-10-29T11:58:58Z
dc.date.issued2013-10
dc.identifier.citationDevelopment and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting. 2013, 21 (10):2759-67 Support Care Canceren
dc.identifier.issn1433-7339
dc.identifier.pmid23715816
dc.identifier.doi10.1007/s00520-013-1843-2
dc.identifier.urihttp://hdl.handle.net/10541/304679
dc.description.abstractA number of risk factors have been implicated in the development of chemotherapy-induced nausea/vomiting (CINV). Our aim was to develop a risk prediction model and identify patients at high risk for developing CINV before their chemotherapy treatment.
dc.language.isoenen
dc.rightsArchived with thanks to Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Canceren
dc.titleDevelopment and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting.en
dc.typeArticleen
dc.contributor.departmentSchool of Nursing, Midwifery & Social Work, University of Manchester, Manchester, UK, alex.molasiotis@polyu.edu.hk.en
dc.identifier.journalSupportive Care in Canceren
html.description.abstractA number of risk factors have been implicated in the development of chemotherapy-induced nausea/vomiting (CINV). Our aim was to develop a risk prediction model and identify patients at high risk for developing CINV before their chemotherapy treatment.


This item appears in the following Collection(s)

Show simple item record